LifeCell International Expands Global Presence With Launch Of Cellution Biologics In The United States

Bangalore, 23rd January

LifeCell International Private Limited, a leading provider of human-based cell and tissue products (HCT/P's) in India, proudly announces the establishment of Cellution Biologics (CB), its wholly owned subsidiary in the United States.

LifeCell International’s facilities are US FDA-registered, and notably is the first tissue bank outside the US to be accredited by the AATB (American Association Of Tissue Banks) for products derived from birth tissues.

As a significant step towards commercial launch of its products in the USA, LifeCell recently obtained recognition from the FDA’s TRG (Tissue Regulatory Authority) for Amchoplast, its range of Amniotic Membrane-based wound care dressings.

Cellution Biologics shall soon establish its distribution centre in Atlanta, and is working towards obtaining necessary coding by Medicaid for reimbursement to providers. CEO of LifeCell International, Sumanth Sarangpani, remarked, "The strategic location of LifeCell in India, the world’s largest birth country, positions Cellution Biologics well to emerge as a global leader in providing high quality, cost effective human-based cell and tissue products”.